Olufunmilayo Olopade to Skin
This is a "connection" page, showing publications Olufunmilayo Olopade has written about Skin.
Connection Strength
0.079
-
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2012 Sep; 48(9):887-92.
Score: 0.079